BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2003
View Archived Issues
PDGF-D: a novel target for the treatment of mesangioproliferative glomerulonephritis
Read More
TV-3326 attenuates MPTP-induced dopaminergic neurotoxicity in mice
Read More
CHF-3381 blocks NMDA receptors in vitro and in vivo
Read More
BN-82451 attenuates striatal lesions in a rat model of Huntington's disease
Read More
ETA receptor antagonism preserves myocardial perfusion response in hypercholesterolemic pigs
Read More
New JNK3 and/or hCK1e inhibitors from fungal origin claimed by Aventis
Read More
Roche and Vernalis present novel 5-HT2C agonists for obesity and other uses
Read More
Novel LXR modulators discovered by Tularik team
Read More
Vicore patent covers new AT2 agonists and their use in dyspepsia, IBS, etc.
Read More
King patents adenosine A2B antagonists with utility in asthma and ocular disorders
Read More
New antithrombotic serine protease inhibitor patented by former Pharmacia
Read More
Nexium intravenous formulation submitted to FDA
Read More
DOS-47 demonstrates preclinical antitumor activity
Read More
Bicifadine as effective as tramadol in phase III pain study
Read More
InNexus and Corixa enter antibody research, development and license agreement
Read More
New trial approved to evaluate GTI-2040 in combination with docetaxel for NSCLC
Read More
Efficacy of drug for dry mouth in preventing lung cancer claimed in recent patent
Read More
New option for patients with lipid disorders introduced in U.S.
Read More
Anti-invasins as a novel class of antifungal agent
Read More
Merck and Alnylam enter RNAi development collaboration
Read More
Valcyte approved for CMV prevention in transplant patients
Read More
New multiple-dose trial evaluates R-112 for allergic rhinitis
Read More
Panacea expands research agreement with MIT
Read More
BresaGen acquires XeriJect drug delivery platform
Read More
Fungicidal compound GL-48656 possesses favorable in vivo properties
Read More
Acylides synthesized at Taisho to overcome resistance in key respiratory tract pathogen
Read More
